Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous urticaria - A real-life experience
Ramit Maoz‐Segal, Tanya Levy, Soad Haj Yahia, et al.
World Allergy Organization Journal (2020) Vol. 13, Iss. 8, pp. 100448-100448
Open Access | Times Cited: 17

Showing 17 citing articles:

The Cow’s Milk Related Symptom Score: The 2022 Update
Yvan Vandenplas, Kateřina Bajerová, Christophe Dupont, et al.
Nutrients (2022) Vol. 14, Iss. 13, pp. 2682-2682
Open Access | Times Cited: 22
Therapies for Chronic Spontaneous Urticaria: Present and Future Developments
Riccardo Asero, Paolo Calzari, Silvia Vaienti, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1499-1499
Open Access | Times Cited: 4
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
Emek Kocatürk, Emel Bülbül Başkan, Özlem Su Küçük, et al.
Anais Brasileiros de Dermatologia (2022) Vol. 97, Iss. 5, pp. 592-600
Open Access | Times Cited: 13
What’s New in the Treatment of Urticaria and Angioedema
David A. Khan, Emek Kocatürk, Andrea Bauer, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 9, Iss. 6, pp. 2170-2184
Closed Access | Times Cited: 16
Evaluation of Cow’s Milk Related Symptom Score [CoMiSS] accuracy in cow’s milk allergy diagnosis
A. Elshafie, Zein A. Omar, Heba M. S. El Zefzaf, et al.
Pediatric Research (2023) Vol. 94, Iss. 3, pp. 987-995
Open Access | Times Cited: 6
UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities
Petra Staubach, Bruna Bianchi Bilo, Joachim W. Fluhr, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Omalizumab withdrawal outcomes in chronic spontaneous urticaria are linked with baseline IgE and eosinophil levels
Ramit Maoz‐Segal, Guy Levenberg, Tanya Levy, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 5, pp. 100905-100905
Open Access | Times Cited: 1
Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab
Haruka Watanabe, Shunsuke Takahagi, Koremasa Hayama, et al.
International Journal of Dermatology (2024)
Open Access | Times Cited: 1
Pediatric chronic spontaneous urticaria: a brief clinician’s guide
Martina Votto, Giovanna Achilli, Maria De Filippo, et al.
Expert Review of Clinical Immunology (2022) Vol. 18, Iss. 9, pp. 889-899
Closed Access | Times Cited: 6
Current and future management of chronic spontaneous urticaria and chronic inducible urticaria
T. Toan, Ethan A. Canty, Shyam Joshi
Allergy and Asthma Proceedings (2022) Vol. 44, Iss. 1, pp. 3-14
Closed Access | Times Cited: 6
Resistant Chronic Spontaneous Urticaria – A Case Series Narrative Review of Treatment Options
Sujoy Khan, Charu Chopra, Alaistair Mitchell, et al.
Allergy & Rhinology (2022) Vol. 13
Open Access | Times Cited: 3
Selective IgE Deficiency Predicts Poor or No Response of Chronic Spontaneous Urticaria to Omalizumab
César Picado, José M. Mascaró, Alexandru Vlagea, et al.
Journal of Investigational Allergology and Clinical Immunology (2022) Vol. 32, Iss. 6, pp. 504-506
Open Access | Times Cited: 1
Combination therapy of omalizumab with house dust mite immunotherapy in chronic spontaneous urticaria associated with sensitization to dust mites-case series
P.C. Kathuria, Manisha Rai
Indian Journal of Case Reports (2021), pp. 469-472
Open Access | Times Cited: 1
Scratching the Itch: Managing Recurrent Pruritic Skin Conditions
Kirti Johal, Cem Akin
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 3, pp. 882-883.e15
Closed Access
Does synthetic pharmacotherapy still have a place in treating chronic spontaneous urticaria?
Rebecca Thiede, Mohammad Fazel, Karen MacDonald, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 14, pp. 1563-1567
Open Access
Omalizumabe versus ciclosporina‐A para o tratamento da urticária crônica espontânea: podemos definir endótipos com melhor resposta?
Emek Kocatürk, Emel Bülbül Başkan, Özlem Su Küçük, et al.
(2022) Vol. 97, Iss. 5, pp. 592-600
Open Access
Practical aspects of treatment with omalizumab in chronic spontaneous urticaria during COVID-19 vaccination campaign
Irina Bucur, Carmen Saviana Ganea, Mariana Vieru, et al.
Alergologia (2021) Vol. 2, Iss. 5, pp. 74-74
Open Access
Page 1

Scroll to top